Generate a tailored SOP for Dr. Kev Dhaliwal. Improve your application with a focused, well-structured draft.
Professor Kev Dhaliwal graduated from the University of Edinburgh and completed general professional training in London before returning to Edinburgh for consolidated laboratory research in the Lung Inflammation Group. He initiated strategic partnerships to develop and translate optical molecular imaging for pulmonary disease. He has completed specialist training in Respiratory Medicine and currently leads the Translational Healthcare Technologies Group, emphasizing collaboration and respect in multidisciplinary interactions. His clinical interest lies in Tuberculosis and pulmonary infections. As co-founder of Edinburgh Molecular Imaging, he also directs the Translational Healthcare Technologies program and the Healthcare Technology Accelerator, fostering relationships with various collaborators to innovate in the field of respiratory medicine. Professor Dhaliwal's research focuses on pivotal methodologies for understanding inflammatory diseases, exploring experimental medicine, and developing transformative devices for enhancing human health.
Department of Marketing